Correction: Obscurins: Goliaths and Davids Take over Non-Muscle Tissues.

Correction: Obscurins: Goliaths and Davids Take over Non-Muscle Tissues.

[This corrects the article DOI: 10.1371/journal.pone.0088162.].

Bibliographic Details
Main Authors:	Maegen A Ackermann, Marey Shriver, Nicole A Perry, Li-Yen R Hu, Aikaterini Kontrogianni-Konstantopoulos
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2018-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5752041?pdf=render

Similar Items

Obscurins: Goliaths and Davids take over non-muscle tissues.
by: Maegen A Ackermann, et al.
Published: (2014-01-01)

Proteomic Analysis of Myocardia Containing the Obscurin R4344Q Mutation Linked to Hypertrophic Cardiomyopathy
by: Li-Yen R. Hu, et al.
Published: (2020-05-01)

Myosin Binding Protein-C Slow: a multifaceted family of proteins with a complex expression profile in fast and slow twitch skeletal muscles
by: Maegen A Ackermann, et al.
Published: (2013-12-01)

Alterations in cytoskeletal and Ca2+ cycling regulators in atria lacking the obscurin Ig58/59 module
by: Alyssa Grogan, et al.
Published: (2023-04-01)

When David takes over Goliath: emerging market firms, M&A; strategy, and post-acquisition integration
by: Szepan, M
Published: (2016)

David versus Goliath in the Food Policy Space
by: Elizabeth Morgan
Published: (2016-12-01)

Alcohol marketing versus public health: David and Goliath?
by: Mary Madden, et al.
Published: (2021-04-01)

Exploring Obscurin and SPEG Kinase Biology
by: Jennifer R. Fleming, et al.
Published: (2021-03-01)

David v. Goliath: The Gay Games, the Olympics, and the Ownership of Language
by: Tarik Sabry
Published: (2016-06-01)

David vs. Goliath: The Structure, Function, and Clinical Prospects of Antibody Fragments
by: Adam Bates, et al.
Published: (2019-04-01)

Fear Goliath or David? Inferring competence from demeanor across cultures
by: Lee, Albert, et al.
Published: (2020)

NLRP3 Inflammasome in Cardiovascular Disease: David`s Stone against Goliath?
by: Serban BALANESCU, et al.
Published: (2021-09-01)

Left pulmonary artery sling and COVID-19: David against Goliath
by: Matteo Renzulli, et al.
Published: (2021-10-01)

David versus Goliath: Radiotheranostic nanomedicine as a weapon against melanoma
by: Luca Filippi, et al.
Published: (2021-01-01)

Goliath
by: Marin Dinu
Published: (2012-02-01)

MYBPC1, an Emerging Myopathic Gene: What we Know, What we Need to Learn
by: Janelle Geist, et al.
Published: (2016-09-01)

David against Goliath? The rise of coastal states at the Indian Ocean Tuna commission
by: Hussain Sinan, et al.
Published: (2022-12-01)

David vs. Goliath: Kaliningrad Oblast as Russia’s A2/AD ‘Bubble’
by: Sergey Sukhankin
Published: (2019-08-01)

Looking like David or Goliath? Cultural differences in display of competence in competitive situation
by: Chan, Lynette Yi Ling
Published: (2015)

David versus Goliath: Tanzania’s Efforts to Stand Up to Foreign Gas Corporations
by: Andrzej Polus, et al.
Published: (2019-04-01)

Non-Inferiority of Sutureless Aortic Valve Replacement in the TAVR Era: David versus Goliath
by: Alina Zubarevich, et al.
Published: (2022-06-01)

Searching for David within the Goliath of alien woody plant invasions in the Western Cape Province
by: Anthony J. Mills, et al.
Published: (2018-09-01)

Microfilariae infestation of goliath frogs (Conraua goliath) from Cameroon.
by: Daniel Nguete Nguiffo, et al.
Published: (2019-01-01)

Large isoforms of UNC-89 (obscurin) are required for muscle cell architecture and optimal calcium release in Caenorhabditis elegans.
by: Patrick M Spooner, et al.
Published: (2012-01-01)

PK1 from Drosophila obscurin is an inactive pseudokinase with scaffolding properties
by: Thomas Zacharchenko, et al.
Published: (2023-04-01)

David versus Goliath : challenges of recruiting and retaining key talent in entrepreneurial, high-technology settings
by: Chan, David Tai Wai
Published: (2016)

Commentary: Epsilon-aminocaproic acid versus tranexamic acid, the David and Goliath of antifibrinolyticsCentral Message
by: David Faraoni, MD, PhD, FAHA
Published: (2020-09-01)

David versus Goliath - The resistance of non-humans in the translation process: the case of the new coronavirus disinteressement
by: EDUARDO GUEDES VILLAR, et al.
Published: (2022-01-01)

Local perceptions, hunting and export of the Endangered Goliath frog Conraua goliath in Cameroon
by: Geraud C. Tasse Taboue, et al.
Published: (2024-01-01)

The Revival of the Battle between David and Goliath in the Enteric Viruses and Microbiota Struggle: Potential Implication for Celiac Disease
by: Aaron Lerner, et al.
Published: (2019-06-01)

David versus goliath: ACE2-Fc receptor traps as potential SARS-CoV-2 inhibitors
by: Mohamed A. Alfaleh, et al.
Published: (2022-12-01)

Impaired Intracellular Ca<sup>2+</sup> Dynamics, M-Band and Sarcomere Fragility in Skeletal Muscles of Obscurin KO Mice
by: Enrico Pierantozzi, et al.
Published: (2022-01-01)

The Japanese mind : the goliath explained /
by: 289325 Christopher, Robert C.
Published: (1983)

Machado vs. the Goliath Chavista
by: Sofía María Fölsch Schroh
Published: (2023-11-01)

What Goliaths and Davids among Swiss firms tell us about expected returns on Swiss asset markets
by: David R. Haab, et al.
Published: (2019-12-01)

THE DAVIDS AND THE GOLIATHS: INVESTMENT DYNAMICS AND PERFORMANCE DIFFERENTIALS OF SMALL FIRMS AND FAMILY-CONTROLLED LARGE FIRMS IN FOUR SECTORS OF THE INDIAN MARKET
by: Jaideep Ghosh
Published: (2021-11-01)

A David and Goliath set-up: a qualitative study of the challenges of ensuring the introduction of cost-effective new cancer medicines in Finland
by: Eeva Ollila, et al.
Published: (2022-12-01)

David contre Goliath : la liaison chez les élèves de FLE face à celle des présentateurs de télévision
by: Heiszenberger Elisabeth, et al.
Published: (2022-01-01)

Do David and Goliath Play the Same Game? Explanation of the Abundance of Rare and Frequent Invasive Alien Plants in Urban Woodlands in Warsaw, Poland.
by: Artur Obidziński, et al.
Published: (2016-01-01)

“More Davids than Goliaths?” A case for the power of small firms to be stronger innovators compared to larger firms during a global pandemic
by: Tyrha M. Lindsey-Warren
Published: (2020-12-01)